We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,406
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEON icon
12676
CALL
Neonode
NEON
$15.3M
$16.6K ﹤0.01%
10,400
+9,300
+845% +$27.1K
WMC
12677
CALL
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$16.6K ﹤0.01%
1,770
LTBR icon
12678
CALL
Lightbridge
LTBR
$317M
$16.6K ﹤0.01%
3,700
-8,200
-69% -$43.1K
TCRT icon
12679
CALL
Alaunos Therapeutics
TCRT
$4.71M
$16.6K ﹤0.01%
839
-438
-34% -$18.9K
RWR icon
12680
PUT
State Street SPDR Dow Jones REIT ETF
RWR
$1.89B
$16.6K ﹤0.01%
200
-4,900
-96% -$440K
CVBF icon
12681
PUT
CVB Financial
CVBF
$4.09B
$16.6K ﹤0.01%
1,000
-8,700
-90% -$148K
LNAI
12682
CALL
Lunai Bioworks
LNAI
$10.1M
$16.5K ﹤0.01%
46
-103
-69% -$15.7K
ORIO
12683
CALL
Orion Digital Corp
ORIO
$20.1M
$16.5K ﹤0.01%
10,529
+96
+0.9% +$185
PLAOW
12684
DELISTED
Patria Latin American Opportunity Acquisition Corp. Warrant
PLAOW
$16.5K ﹤0.01%
274,970
-19,263
-7% -$1.68K
PNNT
12685
PUT
Pennant Park Investment Corp
PNNT
$243M
$16.4K ﹤0.01%
2,500
-2,300
-48% -$14.9K
SXTP icon
12686
60 Degrees Pharmaceuticals
SXTP
$3.42M
$16.4K ﹤0.01%
+92
New +$38.2K
CGEN icon
12687
CALL
Compugen
CGEN
$228M
$16.4K ﹤0.01%
17,600
+800
+5% +$880
ACHV icon
12688
CALL
Achieve Life Sciences
ACHV
$779M
$16.3K ﹤0.01%
3,800
-23,400
-86% -$118K
SBIO icon
12689
CALL
ALPS Medical Breakthroughs ETF
SBIO
$215M
$16.3K ﹤0.01%
600
-7,700
-93% -$232K
PGEN icon
12690
PUT
Precigen
PGEN
$2.18B
$16.3K ﹤0.01%
11,500
-17,100
-60% -$24.2K
PTN
12691
Palatin Technologies
PTN
$16.7M
$16.3K ﹤0.01%
216
-113
-34% -$11.9K
ITRM
12692
DELISTED
Iterum Therapeutics
ITRM
$16.2K ﹤0.01%
+19,566
New +$18.6K
ABVC icon
12693
ABVC BioPharma
ABVC
$24M
$16.2K ﹤0.01%
+15,591
New +$37.7K
RGLS
12694
DELISTED
Regulus Therapeutics
RGLS
$16.2K ﹤0.01%
11,715
-16,090
-58% -$23.3K
BCLI
12695
PUT
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$16.1K ﹤0.01%
5,367
-2,406
-31% -$54.7K
EVGN icon
12696
Evogene
EVGN
$9.49M
$16.1K ﹤0.01%
2,749
+1,539
+127% +$13.5K
EVEX icon
12697
Eve Holding
EVEX
$951M
$16.1K ﹤0.01%
+1,938
New +$16.8K
AQMS icon
12698
CALL
Aqua Metals
AQMS
$9.99M
$16K ﹤0.01%
71
-1
-1% -$239
PPBT
12699
Purple Biotech
PPBT
$2.44M
$16K ﹤0.01%
70
-160
-70% -$38.1K
CCCC icon
12700
CALL
C4 Therapeutics
CCCC
$522M
$16K ﹤0.01%
8,600
-23,100
-73% -$70.5K

Similar funds

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.